NextGen Health
Finnrick has tested 3 samples from NextGen Health across 1 product.
Take Action
Request Full Data Access to the Finnrick database of peptide tests.
Products
| Tests | ||||||||
|---|---|---|---|---|---|---|---|---|
| Product | Rating | Count | Avg | Min | Max | Oldest | Most Recent | |
| Tirzepatide | 3 | 11 Jun 2025 | 4 Nov 2025 | |||||
The NextGen Health samples tested by Finnrick were either acquired by Finnrick directly, or submitted by the public.
Most recent NextGen Health tests
Samples are tested in commercial labs
tests
products
Scores
First
Last
| Quantity | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Product | Certificate | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 4 Nov 2025 | Tirzepatide | View | 10mg | 9.95mg | -0.5% | 99.68% | NG Peptide/Tirz/050625 | No Label / Silver Crimp / White Cap | Lab E | Public | |
| 29 Jun 2025 | Tirzepatide | View | 30mg | 27.3mg | -9.0% | 99.80% | (no batch ID) | No Label / Copper Crimp / Clear Cap | Lab E | Public | |
| 11 Jun 2025 | Tirzepatide | View | 20mg | 19.2mg | -4.0% | 99.81% | (no batch ID) | No Label / Silver Crimp / Grey Cap | Lab E | Public | |
About NextGen Health Test Results From Finnrick
NextGen Health is a peptide vendor with multiple products tracked in the independent testing dataset collected by Finnrick. This page compiles recent, batch-level test results across 1 product and 3 tests, including scores, test dates, batch IDs, and lab details. This enables you to compare quality over time, not just marketing claims.
Each tested sample receives a 0–10 score, with 10 being the best possible value. It is the total of three components: purity (0–4 points), quantity accuracy vs. the label or batch claim (0–4 points), and batch information quality (0–2 points).
When several test results are available for a product and vendor pair, you’ll also find a Finnrick Rating (A–E, where A is best and E is worst, X if an insufficient number of tests is available, or F in rare cases of documented and widespread fraud). Use the table above to review purity, quantity accuracy, consistency between batches, and any notable outliers surfaced in Finnrick testing data.
NextGen Health Testing Activity & Score Summary
In the past 30 days, Finnrick has published no new test results for NextGen Health. The overall dataset includes 3 tested samples with an average score of 7.9/10 across all products.
Across 3 identity-tested samples, 100% were confirmed to contain the expected peptide (identity pass rate). Among those that passed, median purity was 99.8%. Approximately 100% of passing samples tested at or above 98% purity.